Post of the Day | Pokes Report

Forums
Football
- News
- Schedule
- Big 12 Standings
- Roster
- Staff
- Depth Chart
- Class Breakdown
Premium
Basketball
- News
- Schedule
- Big 12 Standings
- Roster
- Staff
- Class Breakdown
Diamond
Olympic
Recruiting
More
- Podcasts
- Search
- Gift Cards
- Help
- Contact Us

subscribe

| Register

Rank

Forum

User

Topic

Stars

1

GumbyFromPokeyLand

Mike Gundy Calls This a Very Important Offseason for Bryan Nardo

2

2

aggie1

Arland Bruce IV Avoids the NCAA Reinstatement Issue and Signs with CFL

2

3

TUSKAPOKE

Oklahoma State Goes to Norman and Wins Bedlam 27-9

1

4

RodeoPoke

Mike Gundy Calls This a Very Important Offseason for Bryan Nardo

1

5

CanadianCowboy

Arland Bruce IV Avoids the NCAA Reinstatement Issue and Signs with CFL

1

6

Joe Khatib

Mike Gundy Calls This a Very Important Offseason for Bryan Nardo

1

7

ehack69

Ollie Gordon II Becomes Oklahoma State's First Doak Walker Award Winner

1

8

Cdub234

Mike Gundy Calls This a Very Important Offseason for Bryan Nardo

1

9

Cdub234

Ollie Gordon II Becomes Oklahoma State's First Doak Walker Award Winner

1

10

Ksquared2015

Mike Gundy Calls This a Very Important Offseason for Bryan Nardo

1

11

ehack69

Michalski Announcement Good for the Offensive Line and He's Part of the Grad Success

1

12

RodeoPoke

Michalski Announcement Good for the Offensive Line and He's Part of the Grad Success

1

13

ehack69

Michalski Announcement Good for the Offensive Line and He's Part of the Grad Success

1

14

ehack69

Alan Bowman NIL Journal No. 18 - Week Off at Home

1

15

TUSKAPOKE

Receiver Blaine Green Enters Transfer Portal

1

16

Joe Khatib

Receiver Blaine Green Enters Transfer Portal

1

17

TUSKAPOKE

Alan Bowman NIL Journal No. 18 - Week Off at Home

1

Follow Pokes Report

Pokes Report is an independent site and is not affiliated with Oklahoma State University. ©2025 Pokes Report. All rights reserved.

×

subscribe Verify your student status

See Subscription Benefits

Trial only available to users who have never subscribed or participated in a previous trial.